4.0 Article

Shared Inherited Genetics of Benign Prostatic Hyperplasia and Prostate Cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Genetics & Heredity

Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

David Conti et al.

Summary: The study identified 86 new genetic risk variants associated with prostate cancer, bringing the total known risk variants to 269. The top genetic risk score decile showed different odds ratios for men of European, African, and East Asian ancestries, highlighting the role of germline variation and providing a potential approach for personalized risk prediction.

NATURE GENETICS (2021)

Article Urology & Nephrology

Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART IdInitial Work-up and Medical Management

Lori B. Lerner et al.

Summary: This article presents guidelines for effective management of male LUTS/BPH. By searching for the latest English language research studies and providing various levels of evidence to support different recommendations, a total of 19 guideline statements related to evaluation, work-up, and medical management were developed.

JOURNAL OF UROLOGY (2021)

Article Urology & Nephrology

Performance of Three Inherited Risk Measures for Predicting Prostate Cancer Incidence and Mortality: A Population-based Prospective Analysis

Zhuqing Shi et al.

Summary: The study suggests that genetic risk score (GRS) complements family history and rare pathogenic mutations as genetic risk measures for assessing the incidence and mortality of prostate cancer.

EUROPEAN UROLOGY (2021)

Article Multidisciplinary Sciences

The UK Biobank resource with deep phenotyping and genomic data

Clare Bycroft et al.

NATURE (2018)

Article Multidisciplinary Sciences

Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA

Julius Gudmundsson et al.

NATURE COMMUNICATIONS (2018)

Article Oncology

Prostate Cancer Early Detection, Version 2.2016

Peter R. Carroll et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2016)

Article Genetics & Heredity

Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data

Stephen Burgess et al.

GENETIC EPIDEMIOLOGY (2013)

Article Urology & Nephrology

OPINION The link between benign prostatic hyperplasia and prostate cancer

David D. Orsted et al.

NATURE REVIEWS UROLOGY (2013)

Article Urology & Nephrology

Impact of medical therapy on transurethral resection of the prostate: two decades of change

Jason Izard et al.

BJU INTERNATIONAL (2011)

Article Medicine, General & Internal

Effect of Dutasteride on the Risk of Prostate Cancer.

Gerald L. Andriole et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Review Urology & Nephrology

Pathology of benign prostatic hyperplasia

C. G. Roehrborn

INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2008)